Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for ...

Bayer is breaking into the irritable bowel syndrome (IBS) therapy market with the acquisition of HiDoc Technologies, which ...

The shift from PVC to PET, while helping the company meet its sustainability goals, was met with challenges, including ...

An investigation conducted by Canada’s National Observer finds that Bayer colluded with Canadian regulators to obstruct a ...

After the recent drop, Bayer is so cheap now that all negativity seems to be priced in. Find out why BAYRY stock is a Buy.

Bayer announced the successful completion of its fall employee engagement campaign with America's Grow-a-Row (AGAR), a New Jersey-based, nonprofit farm where approximately 300 employees harvested 156, ...

KYORIN Pharmaceutical Co.,Ltd. (JP:4569) has released an update. KYORIN Pharmaceutical Co., Ltd. has signed a licensing agreement with Bayer AG to ...

UBS analyst Geoff Haire maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The company’s shares ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) on December 3 and set a price target of €25.00.

Bayer Consumer Health launched a green transportation project in China in November, which is expected to save up to about 13 ...

Leverkusen: Bayer has announced that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start ...